{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:06:36Z","timestamp":1789736796135,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000403","name":"Meningitis Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.vaccine.2021.03.002","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T08:27:55Z","timestamp":1618302475000},"page":"2719-2729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Increase in penicillin-resistant invasive meningococcal serogroup W ST-11 complex isolates in England"],"prefix":"10.1016","volume":"39","author":[{"given":"Laura","family":"Willerton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Lucidarme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiswarya","family":"Lekshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0691-6568","authenticated-orcid":false,"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.vaccine.2021.03.002_b0005","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.vaccine.2019.04.020","article-title":"Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis","volume":"37","author":"Wang","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.03.002_b0010","unstructured":"European Centre for Disease Prevention and Control. Invasive meningococcal disease annual epidemiological report for 2017 [Internet]. Annual epidemiological report on communicable diseases in Europe. 2017. Available from: http:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/AER_for_2017-invasive-meningococcal-disease.pdf"},{"issue":"1","key":"10.1016\/j.vaccine.2021.03.002_b0015","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s12879-019-4146-5","article-title":"Invasive meningococcal disease in patients with complement deficiencies: a case series (2008\u20132017)","volume":"19","author":"Ladhani","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2021.03.002_b0020","doi-asserted-by":"crossref","unstructured":"Fontanals D, Pineda V, Pons I, Rojo JC. Penicillin-resistant beta-lactamase producing Neisseria meningitidis in Spain. Vol. 8, European journal of clinical microbiology & infectious diseases\u00a0: official publication of the European Society of Clinical Microbiology. Germany; 1989. p. 90\u20131.","DOI":"10.1007\/BF01964130"},{"issue":"8328","key":"10.1016\/j.vaccine.2021.03.002_b0025","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(83)91846-9","article-title":"Spread of penicillinase-producing and transfer plasmids from the gonococcus to Neisseria meningitidis","volume":"321","author":"Dillon","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2021.03.002_b0030","doi-asserted-by":"crossref","unstructured":"Botha P. Penicillin-resistant Neisseria meningitidis in southern Africa. Vol. 1, Lancet (London, England). England; 1988. p. 54.","DOI":"10.1016\/S0140-6736(88)91029-X"},{"issue":"1","key":"10.1016\/j.vaccine.2021.03.002_b0035","first-page":"22","article-title":"WGS analysis of a penicillin-resistant Neisseria meningitidis strain containing a chromosomal ROB-1 \u03b2-lactamase gene","volume":"74","author":"Tsang","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.vaccine.2021.03.002_b0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jac\/dkw400","article-title":"Acquisition of beta-lactamase by Neisseria meningitidis through possible horizontal gene transfer","volume":"72","author":"Deghmane","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"24","key":"10.1016\/j.vaccine.2021.03.002_b0045","doi-asserted-by":"crossref","first-page":"735","DOI":"10.15585\/mmwr.mm6924a2","article-title":"Detection of ciprofloxacin-resistant, \u03b2-lactamase-producing Neisseria meningitidis serogroup Y isolates - United States, 2019\u20132020","volume":"69","author":"McNamara","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"10.1016\/j.vaccine.2021.03.002_b0050","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1128\/AAC.00412-07","article-title":"Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis","volume":"51","author":"Taha","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.vaccine.2021.03.002_b0055","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ijmm.2015.08.025","article-title":"Role of penA polymorphisms for penicillin susceptibility in Neisseria lactamica and Neisseria meningitidis","volume":"305","author":"Karch","year":"2015","journal-title":"Int J Med Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2021.03.002_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00207-18","article-title":"Neisseria meningitidis antimicrobial resistance in Italy, 2006 to 2016","volume":"62","author":"Vacca","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"27","key":"10.1016\/j.vaccine.2021.03.002_b0065","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm6627e1","article-title":"High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine","volume":"66","author":"McNamara","year":"2017","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2021.03.002_b0070","doi-asserted-by":"crossref","unstructured":"Parikh SR, Lucidarme J, Bingham C, Warwicker P, Goodship T, Borrow R, et al. Meningococcal B vaccine failure with a penicillin-resistant strain in a young adult on long-term eculizumab. Pediatrics. 2017 Aug 11;140(3).","DOI":"10.1542\/peds.2016-2452"},{"issue":"4","key":"10.1016\/j.vaccine.2021.03.002_b0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/antibiotics5040035","article-title":"Resistance to \u03b2-lactams in Neisseria spp due to chromosomally encoded penicillin-binding proteins","volume":"5","author":"Zapun","year":"2016","journal-title":"Antibiotics"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2021.03.002_b0080","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease","volume":"27","author":"Harrison","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2021.03.002_b0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/14760584.2019.1557520","article-title":"The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations","volume":"18","author":"Acevedo","year":"2019","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2021.03.002_b0090","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/14760584.2017.1258308","article-title":"The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection","volume":"16","author":"Borrow","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2021.03.002_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.07.025","article-title":"Meningococcal disease surveillance in the Asia-Pacific region (2020): The global meningococcal initiative","author":"Aye","year":"2020","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2021.03.002_b0100","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: A portable approach to the identification of clones within populations of pathogenic microorganisms","volume":"95","author":"Maiden","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.vaccine.2021.03.002_b0105","first-page":"861","article-title":"Association of meningococcal serogroups with the course of disease in the Netherlands, 1959\u201383","volume":"65","author":"Spanjaard","year":"1987","journal-title":"Bull World Health Organ"},{"issue":"42","key":"10.1016\/j.vaccine.2021.03.002_b0110","first-page":"21","article-title":"Laboratory-based surveillance for meningococcal disease in selected Areas","volume":"1989\u20131991","author":"Jackson","year":"1993","journal-title":"United States"},{"key":"10.1016\/j.vaccine.2021.03.002_b0115","doi-asserted-by":"crossref","unstructured":"Hansman D. Meningococcal disease in South Australia: incidence and serogroup distribution 1971\u20131980. J Hyg (Lond). 2009\/10\/19. 1983;90(1):49\u201354.","DOI":"10.1017\/S0022172400063828"},{"issue":"7","key":"10.1016\/j.vaccine.2021.03.002_b0120","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1099\/jmm.0.46288-0","article-title":"Epidemiology of meningococcal disease in England and Wales 1993\/94 to 2003\/04: Contribution and experiences of the Meningococcal Reference Unit","volume":"55","author":"Gray","year":"2006","journal-title":"J Med Microbiol"},{"issue":"13","key":"10.1016\/j.vaccine.2021.03.002_b0125","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.vaccine.2016.02.014","article-title":"Global epidemiology of capsular group W meningococcal disease (1970\u20132015): Multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex","volume":"34","author":"Mustapha","year":"2016","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2021.03.002_b0130","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3201\/eid0808.010422","article-title":"Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000","volume":"8","author":"Aguilera","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2021.03.002_b0135","doi-asserted-by":"crossref","unstructured":"Abad R, Lopez EL, Debbag R, V\u00e1zquez JA. Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America. Epidemiol Infect. 2014\/05\/15. 2014;142(12):2461\u201370.","DOI":"10.1017\/S0950268814001149"},{"issue":"SUPPL. 1","key":"10.1016\/j.vaccine.2021.03.002_b0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.vaccine.2007.04.038","article-title":"The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002","volume":"25","author":"Koumar\u00e9","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.03.002_b0145","doi-asserted-by":"crossref","unstructured":"Lucidarme J, Scott KJ, Ure R, Smith A, Lindsay D, Stenmark B, et al. An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup w strain, Scotland and Sweden, July to August 2015. Eurosurveillance. 2016 Nov 10;21(45).","DOI":"10.2807\/1560-7917.ES.2016.21.45.30395"},{"issue":"10","key":"10.1016\/j.vaccine.2021.03.002_b0150","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1016\/S2468-2667(17)30157-3","article-title":"Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study","volume":"2","author":"Knol","year":"2017","journal-title":"Lancet Public Heal"},{"issue":"5","key":"10.1016\/j.vaccine.2021.03.002_b0155","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jinf.2015.07.007","article-title":"Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage","volume":"71","author":"Lucidarme","year":"2015","journal-title":"J Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2021.03.002_b0160","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5694\/mja15.01222","article-title":"Rising incidence of invasive meningococcal disease caused by Neisseria meningitidis serogroup W in Victoria","volume":"204","author":"Bond","year":"2016","journal-title":"Med J Aust"},{"issue":"4","key":"10.1016\/j.vaccine.2021.03.002_b0165","doi-asserted-by":"crossref","first-page":"E454","DOI":"10.33321\/cdi.2016.40.50","article-title":"Rise in invasive serogroup W meningococcal disease in Australia 2013\u20132015","volume":"40","author":"Martin","year":"2016","journal-title":"Commun Dis Intell Q Rep"},{"key":"10.1016\/j.vaccine.2021.03.002_b0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijid.2018.01.019","article-title":"Whole genome typing of the recently emerged Canadian serogroup W Neisseria meningitidis sequence type 11 clonal complex isolates associated with invasive meningococcal disease","volume":"69","author":"Tsang","year":"2018","journal-title":"Int J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2021.03.002_b0175","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3201\/eid2308.170259","article-title":"Clonal expansion of new penicillin-resistant clade of Neisseria meningitidis serogroup w clonal complex 11, Australia","volume":"23","author":"Mowlaboccus","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2021.03.002_b0180","unstructured":"European Committee on Antimicrobial Susceptibility Testing. New definitions of S, I and R from 2019 [Internet]. 2019. Available from: http:\/\/www.eucast.org\/newsiandr\/"},{"issue":"1","key":"10.1016\/j.vaccine.2021.03.002_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2164-15-1138","article-title":"A gene-by-gene population genomics platform: De novo assembly, annotation and genealogical analysis of 108 representative Neisseria meningitidis genomes","volume":"15","author":"Bratcher","year":"2014","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.vaccine.2021.03.002_b0190","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/bioinformatics\/14.1.68","article-title":"SplitsTree: Analyzing and visualizing evolutionary data","volume":"14","author":"Huson","year":"1998","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.vaccine.2021.03.002_b0195","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.molimm.2014.06.030","article-title":"Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach","volume":"61","author":"Grumach","year":"2014","journal-title":"Mol Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2021.03.002_b0200","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/jac\/dkq187","article-title":"Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2","volume":"65","author":"Whiley","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2021.03.002_b0205","doi-asserted-by":"crossref","unstructured":"Maness MJ, Sparling PF. Multiple antibiotic resistance due to a single mutation in Neisseria gonorrhoeae. J Infect Dis [Internet]. 1973 Sep 1;128(3):321\u201330. Available from: https:\/\/doi.org\/10.1093\/infdis\/128.3.321","DOI":"10.1093\/infdis\/128.3.321"},{"issue":"3","key":"10.1016\/j.vaccine.2021.03.002_b0210","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1365-2958.2004.04299.x","article-title":"Modulation of the mtrCDE-encoded efflux pump gene complex of Neisseria meningitidis due to a Correia element insertion sequence","volume":"54","author":"Rouquette-Loughlin","year":"2004","journal-title":"Mol Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2100270X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2100270X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:56:43Z","timestamp":1759402603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2100270X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":42,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0264410X2100270X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.03.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increase in penicillin-resistant invasive meningococcal serogroup W ST-11 complex isolates in England","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}